ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP)

Historical Holders from Q1 2014 to Q3 2025

Symbol
ANIP on Nasdaq
Type / Class
Equity / Common Stock, par value $0.0001 per share
Shares outstanding
22.3M
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
20.4M
Holdings value
$1.87B
% of all portfolios
0.004%
Grand Portfolio weight change
+0%
Number of holders
265
Number of buys
142
Number of sells
-108
Average Value change %
0%
Average buys %
+0.001%
Average sells %
-0.002%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
BlackRock, Inc. 11.3% $231M 2.52M BlackRock, Inc. 30 Sep 2025
Meridian Venture Partners II GP, L.P. 4.8% -12% $66.4M -$9.63M 1.03M -12.7% Robert E. Brown, Jr. 21 Aug 2025
MILLENNIUM MANAGEMENT LLC 3.8% -28% $57.1M -$19M 818K -25% Millennium Management LLC 31 Mar 2025
INTEGRATED CORE STRATEGIES (US) LLC 0.3% -98% $5.98M -$96.3M 65.2K -94.2% Millennium Management LLC 30 Sep 2025

Institutional Holders of ANI PHARMACEUTICALS INC - Common Stock, par value $0.0001 per share (ANIP)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q3 20.4M $1.87B +$53M $91.60 265
2025 Q2 19.7M $1.29B -$20.9M $65.25 229
2025 Q1 20M $1.34B +$48.4M $66.95 226
2024 Q4 19.3M $1.07B +$20.4M $55.28 204
2024 Q3 18.9M $1.13B +$221M $59.66 207
2024 Q2 15.1M $963M +$64.5M $63.68 200
2024 Q1 14.1M $974M +$37.3M $69.13 195
2023 Q4 13.6M $751M +$15M $55.14 180
2023 Q3 13.2M $766M +$52.2M $58.06 184
2023 Q2 12.3M $662M +$105M $53.83 169
2023 Q1 10.4M $412M +$7.76M $39.72 137
2022 Q4 10.3M $413M +$2.39M $40.23 125
2022 Q3 10.3M $330M +$12.9M $32.14 115
2022 Q2 9.88M $293M +$29.9M $29.67 109
2022 Q1 9.21M $259M -$5.75M $28.11 115
2021 Q4 8.97M $413M +$78.2M $46.08 126
2021 Q3 7.28M $239M +$14.4M $32.82 105
2021 Q2 7.2M $252M -$2.87M $35.05 104
2021 Q1 7.29M $263M +$392K $36.14 100
2020 Q4 7.36M $214M +$1.99M $29.04 109
2020 Q3 7.31M $206M -$6.3M $28.21 105
2020 Q2 7.47M $241M -$25.5M $32.34 124
2020 Q1 7.97M $325M -$11.8M $40.74 135
2019 Q4 8.09M $499M -$70.9M $61.67 161
2019 Q3 9.12M $664M +$37.9M $72.88 181
2019 Q2 8.58M $705M +$79.7M $82.20 190
2019 Q1 7.7M $543M +$45.9M $70.54 183
2018 Q4 7.08M $319M -$18.3M $45.02 158
2018 Q3 7.5M $424M +$15.4M $56.54 164
2018 Q2 7.19M $480M +$39.8M $66.80 179
2018 Q1 6.62M $386M +$5.06M $58.22 166
2017 Q4 6.54M $422M +$7.86M $64.45 152
2017 Q3 6.41M $337M -$1.24M $52.49 135
2017 Q2 6.5M $305M +$451K $46.80 145
2017 Q1 6.45M $319M +$59.8M $49.51 151
2016 Q4 6.25M $379M +$11.5M $60.62 151
2016 Q3 6.03M $400M +$29.9M $66.35 166
2016 Q2 5.61M $313M +$11.9M $55.82 134
2016 Q1 5.8M $195M -$21.5M $33.66 115
2015 Q4 6.32M $285M -$31.1M $45.12 119
2015 Q3 6.97M $275M +$17M $39.51 118
2015 Q2 6.49M $403M -$29.2M $62.05 120
2015 Q1 6.96M $435M +$84.6M $62.55 124
2014 Q4 5.63M $317M +$97.1M $56.39 99
2014 Q3 4.53M $129M -$2.97M $28.28 69
2014 Q2 4.49M $155M +$28.4M $34.44 78
2014 Q1 3.76M $118M +$77.3M $31.35 64